Sujan D. Penchala
Liverpool, ENG L78TX, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 24, 2023
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.
Journal: EBioMedicine
Published: February 08, 2023
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 01, 2021
Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial.
Journal: HIV research & clinical practice
Published: November 08, 2021
Total and Unbound Doravirine Concentrations and Viral Suppression in CSF.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 23, 2021
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 14, 2021
Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019.
Journal: Sexually transmitted infections
Published: January 19, 2021
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP).
Journal: The Journal of antimicrobial chemotherapy
Published: January 17, 2021
Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56).
Journal: The Journal of infectious diseases
Published: August 13, 2019
Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat.
Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat.
Journal: HIV research & clinical practice
Published: July 24, 2019
Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in Nigeria.
Journal: International journal of STD & AIDS
Published: December 04, 2018
Last Updated: 09/26/2026